🇺🇸 Premixed insulin in United States

22 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 22

Most-reported reactions

1. Acute Kidney Injury — 5 reports (22.73%)
2. Uraemic Encephalopathy — 4 reports (18.18%)
3. Urinary Retention — 3 reports (13.64%)
4. Basal Cell Carcinoma — 2 reports (9.09%)
5. Bowen'S Disease — 2 reports (9.09%)
6. Hypertension — 2 reports (9.09%)
7. Asthenia — 1 report (4.55%)
8. Chest Pain — 1 report (4.55%)
9. Depression — 1 report (4.55%)
10. Diabetes Mellitus — 1 report (4.55%)

Source database →

Frequently asked questions

Is Premixed insulin approved in United States?

Premixed insulin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Premixed insulin in United States?

Peking University People's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.